Solving the Equity Equation

Startup compensation is often an opaque and awkward topic for first-time academic founders. How much equity do I receive? My CEO? The PI(s)? Other co-founders? How will my choices affect future compensation?

Diving into Academic EIR/MIR Programs: Caltech and Johns Hopkins

In early 2022, OUP hosted a webinar on EIR/MIR Programs at Universities. Due to the overwhelming interest in the topic, we wanted to highlight two additional programs to offer perspectives from other universities. We spoke with Case Cortese, Director for Innovation, New Ventures & Entrepreneurship, to discuss Caltech’s entrepreneur-in-residence (EIR) program, and Mark VanderZyl, Associate…

Webinar: Startup Licensing 101 – Term Sheets & Financials

For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.

Webinar: Life Science Term Sheets

Over the past year, tech transfer directors from Columbia, Duke, JHU, Penn, MIT, Stanford, and Yale worked with life science VCs from 5AM, Atlas, Polaris, OUP, RA Capital, and Venrock to create a common set of principles for university startup deal negotiations. These principles were captured in two documents: “Recommendations for Term Sheet Structuring”, covering equity, royalties, milestones, sublicensing, know-how royalties, diligence, and other recommendations for creating win-win outcomes; and “Recommendations for Process Improvements”, with recommendations for structuring the negotiation process itself to avoid unnecessary friction, gain buy-in early, and avoid overly long and painful negotiations.

Webinar: Startup Licensing 101 – The 30,000 Foot View

This is part 1 of a 5-part webinar series called Startup Licensing 101: A Resource for Entrepreneurs Working with Companies Originated at Academic Institutions.

For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.

Webinar: Life Science Corporate Venture Capital

Corporate VCs have played a crucial role in financing life sciences companies for decades, but have you ever wondered what, if anything, makes them different from institutional venture capital funds? Join us for this webinar as we talk to a panel of investors at industry-leading CVC funds to learn more about their strategies, investment criteria, and how they measure success.

Webinar: How OUP Works With Academic Partners

Since its inception in 2009, OUP’s mission has been to foster deep partnerships with universities with three goals in mind: 1) to invest in their spinouts, 2) to help improve technology transfer effectiveness, and 3) to help improve research commercialization by connecting university startups to our network for funding and recruitment opportunities. Please join OUP for an upcoming webinar where we dive into specifics around how we work with our academic partners and continually work to achieve our mission.

Webinar: Equity Liquidation After IPO Analysis

A common practice across universities that hold equity in a company that IPOs is to sell all of its shares as soon as the lock up expires. But do the best returns necessarily come from selling all your stock immediately? When is the right time to sell stock in a therapeutics company?

Why work in tech transfer? The pandemic has illustrated why people do.

It’s hard to work, write, or think about anything without the context of COVID-19 these days. Living at the intersection of academic institutions and new ventures, I have daily insights into the plethora of programming at universities intended to advance scientific discoveries and see them translated into practice, especially through the activities of the technology…